The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
On the Gov website, our sensitivity is listed 91.3%, is it good enough to get us the DHSC contract extension please? Any views?
i cannot answer your question, but I had always understood our sensitivity was about 99.7% can anyone clarify?
there was a very definite r a c i s t comment that i challenged that has now been deleted
Kaeren yes i agree that was the most important thing!
Kaeren thanks I would have been able to accept that but there were a couple of other posts added to the thread by that time and they are still there
do you notice that my posts were deleted? how can it ever be justified to delete posts that try to maintain decency!!!
After the prompt last night, I looked at the dddd board. He was disparaging of Cpt Tom, and he kept it going!!! they really tore into him. I am sure it was avct that got him banned.
i agree there is no excuse for such a badly worded rns. it does not take more time, it is not a diversion from other strategic or operational tasks. it is a question of having a feel for the communications task and of not being tone deaf. Great company, but they need to recognise they need someone who can supervise the content of communications.
Is that the same NUMIS that put the share price above £13 short term and over £20 mid term????
RottenPig reported for abuse and alerted the admin to consider your past history too
doing tests???
the old ones are the best!!!!
The current culprit is RottenPig . Please do not respond to the post stream and this will probably give them yet another 10p. Their aim is to cause distress and to goad you into replying.
given their history of share price falls on good news in rns(s), this company needs to being in a consultant to review their communications including rns(s) to establish if they are going about things in the right way!
The update gave us what we were expecting, rather than what we were hoping for, and this is great. The sp reaction is, at this point, disappointing: but I have a sense of calm about it as NOW we at least have a solid company information base to work from.
I have benefitted greatly from the research and analysis from others on here and I am sitting on a large profit. This is the first real information we have had from the company since July, and it was only the input from others here that helped me manage the lack of information from the company during that time.. I will not deviate from my complaint about the company's communications with share holders as the lack of information (not just rns's) speaks for itself.
However, today, at last, I feel i have solid information (in the context of great information shared on this board} to make decisions about my holdings.
yemaj good luck with that!!!
Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.
can someone remind me how many tests are in a kit?
has anyone identified a reason for the share price drop?
C S just stop it now we don't not want to listen to your nonsense
i am no expert. but my understanding is that we are listed on the USA equivalent of AIM